Our study with the specific pathway inhibitors in CRC cells suggested that the PI3K/mTOR/AKT pathway acts as an upstream regulator of STAT3 activation in PTEN-deficient CRC cells. The gene discussed is MTOR; the disease is colorectal carcinoma.